Upgrade to SI Premium - Free Trial

After Hours Stocks Movers 08/31: (TRVN) (MTRX) (SUNE) Higher; (ADEP) Lower (more...)

August 31, 2015 5:51 PM
Trevena (NASDAQ: TRVN) 40% HIGHER; announced positive data from its randomized, double-blind, placebo- and active-controlled Phase 2b trial of TRV130 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles